Skip to content

Biocon falls even after subsidiary completes biosimilar integration before schedule

Biocon Biologics acquired all the global biosimilar businesses of Viatris in November 2022.

Read More

​ Biocon Biologics acquired all the global biosimilar businesses of Viatris in November 2022. Biocon Biologics acquired all the global biosimilar businesses of Viatris in November 2022.  Moneycontrol Latest News Read More  

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish